Cargando…

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?

BACKGROUND: The Basque Colorectal Cancer Screening Programme has both high participation rate and high compliance rate of colonoscopy after a positive faecal occult blood test (FIT). Although, colorectal cancer (CRC) screening with biannual (FIT) has shown to reduce CRC mortality, the ultimate effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Arana-Arri, Eunate, Idigoras, Isabel, Uranga, Begoña, Pérez, Raquel, Irurzun, Ana, Gutiérrez-Ibarluzea, Iñaki, Fraser, Callum G., Portillo, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576224/
https://www.ncbi.nlm.nih.gov/pubmed/28851318
http://dx.doi.org/10.1186/s12885-017-3555-3
_version_ 1783260158448631808
author Arana-Arri, Eunate
Idigoras, Isabel
Uranga, Begoña
Pérez, Raquel
Irurzun, Ana
Gutiérrez-Ibarluzea, Iñaki
Fraser, Callum G.
Portillo, Isabel
author_facet Arana-Arri, Eunate
Idigoras, Isabel
Uranga, Begoña
Pérez, Raquel
Irurzun, Ana
Gutiérrez-Ibarluzea, Iñaki
Fraser, Callum G.
Portillo, Isabel
author_sort Arana-Arri, Eunate
collection PubMed
description BACKGROUND: The Basque Colorectal Cancer Screening Programme has both high participation rate and high compliance rate of colonoscopy after a positive faecal occult blood test (FIT). Although, colorectal cancer (CRC) screening with biannual (FIT) has shown to reduce CRC mortality, the ultimate effectiveness of the screening programmes depends on the accuracy of FIT and post-FIT colonoscopy, and thus, harms related to false results might not be underestimated. Current CRC screening programmes use a single faecal haemoglobin concentration (f-Hb) cut-off for colonoscopy referral for both sexes and all ages. We aimed to determine optimum f-Hb cut-offs by sex and age without compromising neoplasia detection and interval cancer proportion. METHODS: Prospective cohort study using a single-sample faecal immunochemical test (FIT) on 444,582 invited average-risk subjects aged 50–69 years. A result was considered positive at ≥20 μg Hb/g faeces. Outcome measures were analysed by sex and age for a wide range of f-Hb cut-offs. RESULTS: We analysed 17,387 positive participants in the programme who underwent colonoscopy. Participation rate was 66.5%. Men had a positivity rate for f-Hb of 8.3% and women 4.8% (p < 0.0001). The detection rate for advanced neoplasia (cancer plus advanced adenoma) was 44.0‰ for men and 15.9‰ for women (p < 0.0001). The number of colonoscopies required decreased in both sexes and all age groups through increasing the f-Hb cut-off. However, the loss in CRC detection increased by up to 28.1% in men and 22.9% in women. CRC missed were generally at early stages (Stage I-II: from 70.2% in men to 66.3% in women). CONCLUSIONS: This study provides detailed outcomes in men and women of different ages at a range of f-Hb cut-offs. We found differences in positivity rates, neoplasia detection rate, number needed to screen, and interval cancers in men and women and in younger and older groups. However, there are factors other than sex and age to consider when consideration is given to setting the f-Hb cut-off.
format Online
Article
Text
id pubmed-5576224
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55762242017-08-30 Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex? Arana-Arri, Eunate Idigoras, Isabel Uranga, Begoña Pérez, Raquel Irurzun, Ana Gutiérrez-Ibarluzea, Iñaki Fraser, Callum G. Portillo, Isabel BMC Cancer Research Article BACKGROUND: The Basque Colorectal Cancer Screening Programme has both high participation rate and high compliance rate of colonoscopy after a positive faecal occult blood test (FIT). Although, colorectal cancer (CRC) screening with biannual (FIT) has shown to reduce CRC mortality, the ultimate effectiveness of the screening programmes depends on the accuracy of FIT and post-FIT colonoscopy, and thus, harms related to false results might not be underestimated. Current CRC screening programmes use a single faecal haemoglobin concentration (f-Hb) cut-off for colonoscopy referral for both sexes and all ages. We aimed to determine optimum f-Hb cut-offs by sex and age without compromising neoplasia detection and interval cancer proportion. METHODS: Prospective cohort study using a single-sample faecal immunochemical test (FIT) on 444,582 invited average-risk subjects aged 50–69 years. A result was considered positive at ≥20 μg Hb/g faeces. Outcome measures were analysed by sex and age for a wide range of f-Hb cut-offs. RESULTS: We analysed 17,387 positive participants in the programme who underwent colonoscopy. Participation rate was 66.5%. Men had a positivity rate for f-Hb of 8.3% and women 4.8% (p < 0.0001). The detection rate for advanced neoplasia (cancer plus advanced adenoma) was 44.0‰ for men and 15.9‰ for women (p < 0.0001). The number of colonoscopies required decreased in both sexes and all age groups through increasing the f-Hb cut-off. However, the loss in CRC detection increased by up to 28.1% in men and 22.9% in women. CRC missed were generally at early stages (Stage I-II: from 70.2% in men to 66.3% in women). CONCLUSIONS: This study provides detailed outcomes in men and women of different ages at a range of f-Hb cut-offs. We found differences in positivity rates, neoplasia detection rate, number needed to screen, and interval cancers in men and women and in younger and older groups. However, there are factors other than sex and age to consider when consideration is given to setting the f-Hb cut-off. BioMed Central 2017-08-29 /pmc/articles/PMC5576224/ /pubmed/28851318 http://dx.doi.org/10.1186/s12885-017-3555-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Arana-Arri, Eunate
Idigoras, Isabel
Uranga, Begoña
Pérez, Raquel
Irurzun, Ana
Gutiérrez-Ibarluzea, Iñaki
Fraser, Callum G.
Portillo, Isabel
Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title_full Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title_fullStr Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title_full_unstemmed Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title_short Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
title_sort population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576224/
https://www.ncbi.nlm.nih.gov/pubmed/28851318
http://dx.doi.org/10.1186/s12885-017-3555-3
work_keys_str_mv AT aranaarrieunate populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT idigorasisabel populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT urangabegona populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT perezraquel populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT irurzunana populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT gutierrezibarluzeainaki populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT frasercallumg populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT portilloisabel populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex
AT populationbasedcolorectalcancerscreeningprogrammesusingafaecalimmunochemicaltestshouldfaecalhaemoglobincutoffsdifferbyageandsex